Proliant takes on cell culture rival
can be used for the production of monoclonal antibodies and other
proteins but is claimed to be more economical than a rival product.
The company said that it is now manufacturing its serum-free LiPro medium on a large scale and can now offer it as an alternative to the Ex-Cyte lipoprotein-based growth media supplement marketed by Serologicals Corp and other rival products.
"LiPro has shown excellent growth and antibody production results against Ex-Cyte and other potential competitors in commonly used hybridoma lines," said Randy Fitzgerald, head of R&D at Proliant. The product has also demonstrated excellent growth results in parent myelomas, CHO, BHK and numerous other mammalian cell lines, he added.
Meanwhile, Proliant said it had also launched a new product - tentatively tradenamed Albuferrin - which is thought to be the only growth-promoting medium on the market that contains both albumin and transferrin. The result should be higher cell growth and hopefully higher yields of protein from cell culture.
Meanwhile, Proliant said it is planning to introduce a new version of its Bovine Serum Albumin (BSA), currently designated 'Biotechnology Grade' and used primarily in diagnostics and for research purposes, that is formulated specifically for cell culture applications.
